Metabomed LTD

Metabomed LTD is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed focuses on the discovery of drugs that inhibit targets that form a synthetic lethal gene pair with metabolic genes inactivated in cancer cells. Metabomed operates out of MS Ventures Bioincubator in Yavne, Israel.

Latest News Entry
Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing

Israeli cancer metabolism company Metabomed LTD. announced today that it has completed an extension of its Series A round from current and new investors bringing the total of its

all portfolio news